Is Semaglutide Banned by WADA? The Facts for Athletes

You're an athlete and your doctor has mentioned semaglutide, here's where you actually stand

Picture this: your GP or a specialist has raised semaglutide as a treatment option, and your first thought is whether it will put your competitive licence at risk. It's a fair concern, and one that anti-doping staff hear with increasing frequency as GLP-1 medicines become more mainstream.

The current answer is clear. WADA's 2025 Prohibited List (the authoritative global reference for competitive sport) does not name semaglutide in any of its prohibited categories, whether for in-competition use, out-of-competition use, or in specific sports. Semaglutide acts on the GLP-1 receptor to reduce appetite and slow gastric emptying; it does not enhance oxygen-carrying capacity, stimulate muscle growth, or mask other prohibited substances. Those mechanisms are the primary criteria WADA uses when evaluating whether a compound warrants prohibition.

You can verify the current status yourself through the WADA Prohibited List directly. It is updated each January. Checking it yourself (rather than relying on a third party) is the standard of care expected of athletes under the strict-liability principle that governs most anti-doping codes.

One practical point: national governing bodies and individual sports federations sometimes maintain supplementary rules that go beyond WADA's list. If you compete at elite level in a sport with its own additional code, confirm with your federation's anti-doping officer rather than assuming WADA's list is the whole picture.

Why athletes are asking about semaglutide more than they used to

The rise in questions reflects how rapidly semaglutide has moved from a specialist prescription to a widely discussed treatment. Clinical trial results published in the New England Journal of Medicine (STEP 1, 68 weeks) showed average weight reductions of around 15% in adults with obesity, and that kind of data tends to travel fast.

Weight category sports (boxing, wrestling, rowing, weightlifting, judo) have obvious reasons to pay attention. An athlete managing body composition with a licensed medicine is doing something fundamentally different from someone doping to improve performance, but the question of whether a substance is prohibited is separate from the question of intent. WADA's list is substance-specific, not motive-specific.

So far, WADA's scientific committees have not indicated that semaglutide's mechanism offers a performance advantage in healthy athletes without a weight-related condition. Reduced caloric intake can itself affect endurance performance negatively if not managed carefully, something worth discussing with both your prescriber and your sports nutrition support. The NHS medicines page for semaglutide gives a clear overview of how the medicine works and its known side-effect profile, which athletes may find useful when considering its practical impact on training.

For context on the broader GLP-1 receptor agonist class, our overview of GLP-1 receptor agonists explains how these medicines compare and what conditions they are licensed to treat in the UK.

What 'not currently banned' does not mean

Being off WADA's Prohibited List is not the same as being unrestricted. Several points are worth keeping in mind.

First, WADA can add any substance to the list at any time if new evidence suggests performance-enhancing potential or a health risk. Athletes who start a course of treatment have no guarantee the position remains unchanged throughout, though in practice, list changes come with advance notice and a formal consultation period.

Second, semaglutide is a prescription-only medicine in the UK under the Human Medicines Regulations. It cannot be obtained legally without a valid prescription following clinical assessment. Purchasing it without a prescription from unverified online sources is not only a legal risk; it also creates supply-chain uncertainty that any serious athlete should want to avoid. The MHRA has warned publicly about counterfeit weight-loss pens circulating online, some containing entirely different active substances. You can report suspect sellers at the MHRA's Yellow Card scheme.

Third, if semaglutide were ever added to the Prohibited List, athletes already using it for a genuine medical condition would need to apply for a Therapeutic Use Exemption (TUE) to continue competing. That process requires documented clinical evidence of medical need. Starting treatment through a regulated clinical route (with proper records) is far simpler to evidence in a TUE application than treatment obtained informally.

For anyone curious about what private semaglutide treatment typically costs in the UK, our Wegovy pricing page sets out the context honestly without hidden fees.

The clinical route for athletes who are medically eligible

Athletes who meet clinical criteria for semaglutide (BMI of 30 or above, or 27 or above with a weight-related condition such as high blood pressure or dyslipidaemia) can pursue treatment through a regulated UK prescriber, and our pages covering semaglutide 1 and semaglutide 2 explain the different dose stages involved in a typical treatment course. The medicine is licensed; it is not prohibited; and managing a genuine health condition is exactly what the TUE framework was designed to accommodate if that situation ever changed.

At nume, a GPhC-registered Independent Prescriber personally reviews every consultation, the same day it arrives. That means a real clinician reads your health history, not an automated triage tool. If treatment is clinically suitable, your prescription is issued and your medicine dispatched the same working day (orders in before midday, Monday to Friday), with free next-working-day delivery via DPD in plain packaging.

You can find a full picture of what treatment involves on our weight-loss treatment overview, or speak to the team directly via our contact page. If you'd like to understand the clinical team behind the service, our lead prescriber's profile is a good place to start.

The question this page answers is a narrow one, anti-doping status. The broader clinical question, whether semaglutide is right for you given your training load, nutrition targets, and health profile, is one to work through with a prescriber. That's what the consultation is for.